Evaluation of statin utilization in the Republic of Macedonia during 2013-2016.

Clinicoecon Outcomes Res · 2018 · PMC6027697 · PMID 29983582

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

The average HIF costs for this group of drugs was €10.8 million in the period from 2013 to 2015 with an increasing trend of approximately 6.5–7.1% each year.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.